查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869971

痔疮治疗市场规模、份额和趋势分析报告：按疾病、药物类别、分销管道、地区和细分市场预测（2025-2033 年）

Hemorrhoids Treatment Market Size, Share & Trends Analysis Report By Disease (Internal Hemorrhoids, External Hemorrhoids), By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

痔疮治疗中心摘要

2024年全球痔疮治疗市场规模估计为7.6299亿美元，预计2033年将达到14.6528亿美元。

预计从 2025 年到 2033 年，该市场将以 7.5% 的复合年增长率成长。市场成长的驱动因素是痔疮盛行率的上升，而痔疮盛行率上升的原因是久坐不动的生活方式、不良的饮食习惯、肥胖症的增加以及人口老化导致组织弹性下降等因素。

例如，根据2024年12月《疾病与全球健康杂誌》的一篇文章，全球50%至85%的人口一生中会患痔疮，其中四分之一的非洲50岁以上人群受其影响。同一项研究报告称，在美国，因痔疮就诊的门诊患者达330万人次，使其成为门诊就诊的第四大常见胃肠道疾病。轻度至中度痔疮可透过摄取纤维、补充水分和坐浴进行治疗，而重度痔疮则需采用橡皮筋结扎术、硬化疗法和红外线凝固术。晚期痔疮则需要进行痔疮钉合术或动脉结扎术，术后护理包括控制疼痛、出血和闭尿症。人们对痔疮的认识不断提高，诊断技术的进步也推动了及时介入和治疗需求的成长。

痔疮治疗技术的创新正在改变患者照护，并推动市场扩张。微创手术，如橡皮筋结扎术、红外线凝固术和雷射疗法，因其缩短恢復时间、减轻疼痛和减少併发症而吸引了更多患者。先进的局部用药和口服药物能够改善症状控制并提高患者依从性，而创新的联合疗法则能从多个方面治疗疾病。例如，根据2024年6月发表在《韩国生物医学评论》上的一篇文章，全球超过80%的人口一生中都会患上痔疮，其中45至65岁人群的患病率超过50%。该报导强调了早期诊断、制定合适的治疗策略以及调整生活方式（包括饮食改善和增加运动）对于控制和预防併发症的重要性。诊所和医院正越来越多地采用这些手术方法，以优化治疗效果和效率，并减少住院时间和术后追踪的需求。治疗方式和治疗技术的不断改进，促进了这些疗法的更广泛应用，推动了它们在全球已开发市场和新兴市场的成长。

消费者对便利、有效且易于取得的痔疮治疗方法的需求正在推动市场进一步成长。非处方药膏、栓剂和口服补充剂为患者提供了在家中自我护理的实用选择，同时，意识提升也鼓励他们积极主动地管理症状。行销宣传活动、宣传活动和数位平台突显了现代治疗方法的益处和易用性，从而提高了患者的参与度。不断拓展的通路，包括药局、专科诊所和电商平台，确保了更广泛的供应和便利性。随着患者越来越倾向于安全、微创且可在家中进行的治疗方案，製造商和医疗机构不断创新，推出新产品和治疗方案，以满足不断变化的消费者期望和需求。

目录

第一章调查方法和范围

第二章执行摘要

第三章 痔疮治疗市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 定价分析

第四章 痔疮治疗市场：依疾病分类的商业分析

  • 疾病市场份额，2024 年和 2033 年
  • 疾病细分仪表板
  • 市场规模与预测、疾病特定趋势分析，2021-2033年
  • 内痔
  • 外痔
  • 混合型痔疮

第五章 痔疮治疗市场：依药物类别分類的业务分析

  • 2024 年及 2033 年各药物类别市占率
  • 药物类别细分仪表板
  • 按药物类别分類的市场规模、预测和趋势分析，2021-2033年
  • 皮质类固醇
  • 局部麻醉剂
  • 血管收缩剂
  • 其他的

第六章 痔疮治疗市场：依分销管道分類的业务分析

  • 2024 年及 2033 年分销通路市场份额
  • 分销通路细分仪表板
  • 按分销管道分類的市场规模、预测和趋势分析，2021-2033年
  • 网路药房
  • 零售药房
  • 医院药房

第七章 痔疮治疗市场：区域估算与趋势分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场概览
  • 市场规模及预测趋势分析（2021-2033）：
  • 北美洲
    • 按国家/地区划分，2021-2033 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 参与者概览
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介
    • Lupin
    • Cipla
    • Amato Pharmaceutical Products, Ltd.
    • Church &Dwight Co., Inc
    • Haleon Group of Companies
    • Sebela Pharmaceuticals
    • Bayer AG
    • Sanofi
    • Abbott
    • Sun Pharmaceutical Industries, Inc
Product Code: GVR-4-68040-783-7

Hemorrhoids Treatment Market Summary

The global hemorrhoids treatment market size was estimated at USD 762.99 million in 2024 and is projected to reach USD 1,465.28 million by 2033, growing at a CAGR of 7.5% from 2025 to 2033. The increasing prevalence of hemorrhoidal disorders is driving market growth, influenced by sedentary lifestyles, poor diets, rising obesity, and aging, which reduces tissue elasticity.

For instance, in December 2024, Journal of Disease and Global Health reported that 50% to 85% of the global population experienced hemorrhoids in their lifetime, with one-quarter of Africans over 50 affected. The study noted 3.3 million U.S. ambulatory-care visits, making hemorrhoids the fourth most common gastrointestinal disorder in outpatient settings. Mild to moderate cases were managed with fiber, hydration, and sitz baths, while severe cases used rubber band ligation, sclerotherapy, or infrared coagulation. Advanced cases required stapled hemorrhoidopexy or artery ligation, with postoperative care addressing pain, bleeding, and urinary retention. Greater awareness and diagnostic advances are driving timely interventions and treatment demand.

Technological innovations in hemorrhoid treatment methods are transforming patient care and supporting market expansion. Minimally invasive procedures, such as rubber band ligation, infrared coagulation, and laser therapy, offer faster recovery, reduced pain, and minimal complications, attracting more patients. Advanced topical formulations and oral medications improve symptom management and enhance patient adherence, while innovative combination therapies address multiple aspects of the disorder. For instance, in June 2024, Korea Biomedical Review reported that over 80% of the global population experiences hemorrhoids at some point, particularly individuals aged 45 to 65, with prevalence exceeding 50% in those over 50. The article emphasized early diagnosis, appropriate treatment strategies, and lifestyle modifications, including dietary changes and exercise, to manage and prevent complications. Clinics and hospitals increasingly implement these procedures to optimize outcomes and efficiency, reducing hospital stays and post-treatment follow-up requirements. Continuous improvements in treatment delivery and procedural techniques encourage wider adoption of these therapies, fostering growth across both developed and emerging markets globally.

Consumer demand for convenient, effective, and accessible hemorrhoid treatments is fueling market growth further. Over-the-counter ointments, suppositories, and oral supplements provide patients with practical options for self-care at home, while increasing awareness of lifestyle interventions encourages proactive symptom management. Marketing campaigns, educational initiatives, and digital platforms highlight the advantages and ease of use of modern treatments, enhancing patient engagement. Expanding distribution channels, including pharmacies, specialty clinics, and e-commerce platforms, ensure wider availability and accessibility. As patients increasingly prefer safe, minimally invasive, and home-based treatment solutions, manufacturers and healthcare providers continue to innovate, introducing new products and therapeutic options that meet evolving consumer expectations and needs.

Global Hemorrhoids Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hemorrhoids treatment market report based on disease, drug class, distribution channel, and region:

  • Disease Outlook (Revenue, USD Million, 2021 - 2033)
  • Internal Hemorrhoids
  • External Hemorrhoids
  • Mixed Hemorrhoids
  • Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
  • Corticosteroids
  • Local Anesthetics
  • Vasoconstrictors
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Drug Class
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hemorrhoids Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Pricing Analysis

Chapter 4. Hemorrhoids Treatment Market: Disease Business Analysis

  • 4.1. Disease Market Share, 2024 & 2033
  • 4.2. Disease Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
  • 4.4. Internal Hemorrhoids
    • 4.4.1. Internal Hemorrhoids Market, 2021 - 2033 (USD Million)
  • 4.5. External Hemorrhoids
    • 4.5.1. External Hemorrhoids Market, 2021 - 2033 (USD Million)
  • 4.6. Mixed Hemorrhoids
    • 4.6.1. Mixed Hemorrhoids Market, 2021 - 2033 (USD Million)

Chapter 5. Hemorrhoids Treatment Market: Drug Class Business Analysis

  • 5.1. Drug Class Market Share, 2024 & 2033
  • 5.2. Drug Class Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 5.4. Corticosteroids
    • 5.4.1. Corticosteroids Market, 2021 - 2033 (USD Million)
  • 5.5. Local Anesthetics
    • 5.5.1. Local Anesthetics Market, 2021 - 2033 (USD Million)
  • 5.6. Vasoconstrictors
    • 5.6.1. Vasoconstrictors Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Hemorrhoids Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2033
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4. Online Pharmacy
    • 6.4.1. Online Pharmacy Market, 2021 - 2033 (USD Million)
  • 6.5. Retail Pharmacy
    • 6.5.1. Retail Pharmacy Market, 2021 - 2033 (USD Million)
  • 6.6. Hospital Pharmacy
    • 6.6.1. Hospital Pharmacy Market, 2021 - 2033 (USD Million)

Chapter 7. Hemorrhoids Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Hemorrhoids Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. Uk Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Lupin
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Cipla
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Amato Pharmaceutical Products, Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Church & Dwight Co., Inc
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Haleon Group of Companies
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Sebela Pharmaceuticals
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Bayer AG
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Sanofi
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Abbott
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sun Pharmaceutical Industries, Inc
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global hemorrhoids treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 5. Global hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 6. Global hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 7. North America hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 8. North America hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 9. North America hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 10. North America hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11. U.S. hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 12. U.S. hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 13. U.S. hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 14. Canada hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 15. Canada hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 16. Canada hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 17. Mexico hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 18. Mexico hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 19. Mexico hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20. Europe hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 21. Europe hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 22. Europe hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 23. Europe hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24. UK hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 25. UK hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 26. UK hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 27. Germany hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 28. Germany hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 29. Germany hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30. France hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 31. France hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 32. France hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 33. Italy hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 34. Italy hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 35. Italy hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 36. Spain hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 37. Spain hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 38. Spain hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 39. Norway hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 40. Norway hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 41. Norway hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 42. Denmark hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 43. Denmark hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 44. Denmark hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 45. Sweden hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 46. Sweden hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 47. Sweden hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD
  • Table 52. Japan hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 53. Japan hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 54. Japan hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 55. China hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 56. China hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 57. China hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 58. India hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 59. India hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 60. India hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61. Australia hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 62. Australia hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 63. Australia hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 64. South Korea hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 65. South Korea hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 66. South Korea hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 67. Thailand hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 68. Thailand hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 69. Thailand hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 70. Latin America hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 71. Latin America hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 72. Latin America hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 73. Latin America hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 74. Brazil hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 75. Brazil hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 76. Brazil hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 77. Argentina hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 78. Argentina hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 79. Argentina hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 83. Middle East & Africa hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 84. South Africa hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 85. South Africa hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 86. South Africa hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 90. UAE hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 91. UAE hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 92. UAE hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 93. Kuwait hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 94. Kuwait hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 95. Kuwait hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Hemorrhoids treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Hemorrhoids treatment market dynamics
  • Fig. 12 Hemorrhoids treatment market: Porter's five forces analysis
  • Fig. 13 Hemorrhoids treatment market: PESTLE analysis
  • Fig. 14 Disease market, 2021 - 2033 (USD Million)
  • Fig. 15 Internal Hemorrhoids market, 2021 - 2033 (USD Million)
  • Fig. 16 External Hemorrhoids market, 2021 - 2033 (USD Million)
  • Fig. 17 Mixed Hemorrhoids market, 2021 - 2033 (USD Million)
  • Fig. 18 Drug Class market, 2021 - 2033 (USD Million)
  • Fig. 19 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 20 Local Anesthetics market, 2021 - 2033 (USD Million)
  • Fig. 21 Vasoconstrictors market, 2021 - 2033 (USD Million)
  • Fig. 22 Others market, 2021 - 2033 (USD Million)
  • Fig. 23 Distribution channel market, 2021 - 2033 (USD Million)
  • Fig. 24 Online pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 25 Retail pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 26 Hospital pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 27 Hemorrhoids treatment market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 MEA hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework